Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab

What is it about?

Patients with asthma often fail to take their preventer inhaler treatment. We looked at a group of asthmatics who were on long term treatment with Omalizumab, a drug used to treat severe allergic asthma. Before starting treatment all patients had to be taking their preventer treatment regularly (defined as at least 8 out of 10 times). In our study we found that half the patients were no longer taking their preventer treatment regularly. These patients did not have any significant differences in lung function or airway inflammation compared to the patients who continued to take their preventer inhalers. There was no significant difference in how well controlled their asthma was. We think that patients, if they remain well are more likely to stop taking their inhaler therapy regularly.

Featured Image